English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/203095
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:


DNA damage response-related alterations define the genetic background of patients with chronic lymphocytic leukemia and chromosomal gains

AuthorsHernández-Sánchez, María; Rodríguez-Vicente, Ana Eugenia; González-Gascón y Marín, Isabel; Quijada-Álamo, Miguel; Hernandez-Sánchez, Jesus M.; Martín-Izquierdo, Marta; Hernández-Rivas, José Ángel; Benito, Rocío; Hernández, Jesús M.
Issue DateApr-2019
CitationExperimental Hematology 72: 9-13 (2019)
AbstractThe presence of chromosomal gains other than trisomy 12 suggesting a hyperdiploid karyotype is extremely rare in chronic lymphocytic leukemia (CLL) and is associated with a dismal prognosis. However, the genetic mechanisms and mutational background of these patients have not been fully explored. To improve our understanding of the genetic underpinnings of this subgroup of CLL, seven CLL patients with several chromosomal gains were sequenced using a next-generation sequencing (NGS)-targeted approach. The mutational status of 54 genes was evaluated using a custom-designed gene panel including recurrent mutated genes observed in CLL and widely associated with CLL pathogenesis. A total of 21 mutations were detected; TP53 (42.8%), ATM (28.5%), SF3B1 (28.5%), and BRAF (28.5%) were the most recurrently mutated genes. Of these mutations, 61.9% were detected in genes previously associated with a poor prognosis in CLL. Interestingly, five of the seven patients exhibited alterations in TP53 or ATM (deletion and/or mutation), genes involved in the DNA damage response (DDR), which could be related to a high genetic instability in this subgroup of patients. In conclusion, CLL patients with several chromosomal gains exhibit high genetic instability, with mutations in CLL driver genes and high-risk genetic alterations involving ATM and/or TP53 genes.
Publisher version (URL)http://dx.doi.org/10.1016/j.exphem.2019.02.003
Appears in Collections:(CIC) Artículos
(IBMCC) Artículos
Files in This Item:
File Description SizeFormat 
accesoRestringido.pdf15,38 kBAdobe PDFThumbnail
Show full item record
Review this work

Related articles:

WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.